Bakar Bio Labs, 2625 Durant Ave., Berkeley
QB3 Symposium
Symposium crowd

While often discussed through the lens of fertility and menopause, the ovaries play a much broader role in regulating whole-body health—shaping metabolism, cardiovascular function, bone density, immune regulation, and brain aging. This becomes especially clear after menopause, when the risks for age-related diseases — including cardiovascular disease, dementia, osteoporosis, and metabolic diseases — rise significantly.

Yet we still lack a complete understanding of what drives ovarian aging and how it contributes to systemic decline. Hormone therapy remains the primary clinical option, but innovation has been limited for decades. This is a major opportunity for new diagnostics and treatments that target the ovaries themselves.

Advances in single-cell and spatial sequencing, organoid and model systems, and clinical studies are now accelerating progress, revealing new paths for early intervention and therapeutic development. This convergence of scientific opportunity and unmet need inspired QB3 to focus this year’s symposium on ovarian health and the systemic consequences of ovarian aging.

Network with scientists, entrepreneurs, industry representatives, and investors.

Sessions include:

  • Molecular and Spatial Mapping of Ovarian Aging and Disease

  • Pre-Clinical Models of Ovarian Biology

  • Beyond Fertility: System-Wide Influence of the Ovary

  • Building Momentum: Current Advances and Strategic Opportunities

  • From Discovery to Impact: Investing in Healthspan Innovation

 

View the Agenda & Request to Attend

Please RSVP by March 31.